BioLife Solutions, Inc. (NASDAQ:BLFS) had its price objective lifted by Maxim Group from $6.00 to $7.00 in a research note issued to investors on Tuesday morning, Marketbeat.com reports. They currently have a buy rating on the medical equipment provider’s stock.

Separately, Janney Montgomery Scott raised shares of BioLife Solutions from a neutral rating to a buy rating and increased their price target for the company from $2.62 to $5.00 in a research note on Wednesday, July 5th.

BioLife Solutions (NASDAQ BLFS) opened at 5.39 on Tuesday. BioLife Solutions has a 12 month low of $1.43 and a 12 month high of $5.91. The firm’s 50 day moving average price is $4.41 and its 200 day moving average price is $2.88. The stock’s market cap is $71.30 million.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings results on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). BioLife Solutions had a negative net margin of 63.71% and a negative return on equity of 64.98%. The business had revenue of $2.56 million during the quarter, compared to analysts’ expectations of $2.40 million. On average, equities research analysts predict that BioLife Solutions will post ($0.24) EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “BioLife Solutions, Inc. (BLFS) Given New $7.00 Price Target at Maxim Group” was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/09/22/biolife-solutions-inc-blfs-given-new-7-00-price-target-at-maxim-group.html.

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.